vs
InfuSystem Holdings, Inc（INFU）与RE/MAX Holdings, Inc.（RMAX）财务数据对比。点击上方公司名可切换其他公司
RE/MAX Holdings, Inc.的季度营收约是InfuSystem Holdings, Inc的2.0倍（$71.1M vs $36.2M），InfuSystem Holdings, Inc同比增速更快（7.0% vs -1.8%），RE/MAX Holdings, Inc.自由现金流更多（$33.5M vs $7.0M），过去两年InfuSystem Holdings, Inc的营收复合增速更高（6.4% vs -4.7%）
InfuSystem Holdings, Inc.是总部位于美国的医疗服务及设备供应商，主打输液治疗解决方案，提供可编程输液泵、配套一次性医用耗材及专业临床支持服务，服务覆盖北美地区的肿瘤诊所、家庭医疗服务商及急症护理机构。
RE/MAX是全球知名的房地产特许经营机构，业务遍布全球一百多个国家和地区，旗下拥有数千家门店，总计超过十万名房产经纪人，在国际房产中介领域拥有极高的品牌知名度与市场影响力。
INFU vs RMAX — 直观对比
营收规模更大
RMAX
是对方的2.0倍
$36.2M
营收增速更快
INFU
高出8.9%
-1.8%
自由现金流更多
RMAX
多$26.5M
$7.0M
两年增速更快
INFU
近两年复合增速
-4.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $36.2M | $71.1M |
| 净利润 | — | $1.4M |
| 毛利率 | 56.4% | — |
| 营业利润率 | 10.3% | 13.1% |
| 净利率 | — | 2.0% |
| 营收同比 | 7.0% | -1.8% |
| 净利润同比 | — | -75.2% |
| 每股收益（稀释后） | $0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INFURMAX
| Q4 25 | $36.2M | $71.1M | ||
| Q3 25 | $36.5M | $73.2M | ||
| Q2 25 | $36.0M | $72.8M | ||
| Q1 25 | $34.7M | $74.5M | ||
| Q4 24 | $33.8M | $72.5M | ||
| Q3 24 | $35.3M | $78.5M | ||
| Q2 24 | $33.7M | $78.5M | ||
| Q1 24 | $32.0M | $78.3M |
净利润INFURMAX
| Q4 25 | — | $1.4M | ||
| Q3 25 | $2.3M | $4.0M | ||
| Q2 25 | $2.6M | $4.7M | ||
| Q1 25 | $-267.0K | $-2.0M | ||
| Q4 24 | — | $5.8M | ||
| Q3 24 | $1.8M | $966.0K | ||
| Q2 24 | $717.0K | $3.7M | ||
| Q1 24 | $-1.1M | $-3.4M |
毛利率INFURMAX
| Q4 25 | 56.4% | — | ||
| Q3 25 | 57.1% | — | ||
| Q2 25 | 55.2% | — | ||
| Q1 25 | 55.2% | — | ||
| Q4 24 | 53.8% | — | ||
| Q3 24 | 53.9% | — | ||
| Q2 24 | 49.5% | — | ||
| Q1 24 | 51.5% | — |
营业利润率INFURMAX
| Q4 25 | 10.3% | 13.1% | ||
| Q3 25 | 10.4% | 25.0% | ||
| Q2 25 | 10.5% | 19.3% | ||
| Q1 25 | 1.8% | 7.2% | ||
| Q4 24 | 7.7% | 5.9% | ||
| Q3 24 | 9.2% | 19.4% | ||
| Q2 24 | 5.5% | 20.6% | ||
| Q1 24 | -2.6% | 5.8% |
净利率INFURMAX
| Q4 25 | — | 2.0% | ||
| Q3 25 | 6.2% | 5.4% | ||
| Q2 25 | 7.2% | 6.4% | ||
| Q1 25 | -0.8% | -2.6% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | 5.1% | 1.2% | ||
| Q2 24 | 2.1% | 4.7% | ||
| Q1 24 | -3.5% | -4.3% |
每股收益（稀释后）INFURMAX
| Q4 25 | $0.09 | — | ||
| Q3 25 | $0.11 | — | ||
| Q2 25 | $0.12 | — | ||
| Q1 25 | $-0.01 | — | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.08 | — | ||
| Q2 24 | $0.03 | — | ||
| Q1 24 | $-0.05 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.2M | $118.7M |
| 总债务越低越好 | $19.6M | $432.2M |
| 股东权益账面价值 | $57.3M | $452.4M |
| 总资产 | $100.6M | $582.5M |
| 负债/权益比越低杠杆越低 | 0.34× | 0.96× |
8季度趋势，按日历期对齐
现金及短期投资INFURMAX
| Q4 25 | $3.2M | $118.7M | ||
| Q3 25 | $955.0K | $107.5M | ||
| Q2 25 | $720.0K | $94.3M | ||
| Q1 25 | $1.5M | $89.1M | ||
| Q4 24 | $527.0K | $96.6M | ||
| Q3 24 | $380.0K | $83.8M | ||
| Q2 24 | $146.0K | $66.1M | ||
| Q1 24 | $822.0K | $82.1M |
总债务INFURMAX
| Q4 25 | $19.6M | $432.2M | ||
| Q3 25 | $20.9M | $433.3M | ||
| Q2 25 | $26.3M | $434.4M | ||
| Q1 25 | $28.7M | $435.3M | ||
| Q4 24 | $23.9M | $436.2M | ||
| Q3 24 | $28.0M | $437.2M | ||
| Q2 24 | $34.2M | $438.1M | ||
| Q1 24 | $29.9M | $439.0M |
股东权益INFURMAX
| Q4 25 | $57.3M | $452.4M | ||
| Q3 25 | $55.5M | $448.1M | ||
| Q2 25 | $54.5M | $442.4M | ||
| Q1 25 | $55.1M | $433.5M | ||
| Q4 24 | $57.5M | $429.5M | ||
| Q3 24 | $55.5M | $423.1M | ||
| Q2 24 | $53.5M | $418.4M | ||
| Q1 24 | $52.3M | $412.0M |
总资产INFURMAX
| Q4 25 | $100.6M | $582.5M | ||
| Q3 25 | $98.9M | $582.2M | ||
| Q2 25 | $100.8M | $574.8M | ||
| Q1 25 | $104.3M | $571.4M | ||
| Q4 24 | $103.6M | $581.6M | ||
| Q3 24 | $105.3M | $578.6M | ||
| Q2 24 | $108.5M | $571.4M | ||
| Q1 24 | $104.8M | $566.7M |
负债/权益比INFURMAX
| Q4 25 | 0.34× | 0.96× | ||
| Q3 25 | 0.38× | 0.97× | ||
| Q2 25 | 0.48× | 0.98× | ||
| Q1 25 | 0.52× | 1.00× | ||
| Q4 24 | 0.41× | 1.02× | ||
| Q3 24 | 0.50× | 1.03× | ||
| Q2 24 | 0.64× | 1.05× | ||
| Q1 24 | 0.57× | 1.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $7.1M | $40.9M |
| 自由现金流经营现金流 - 资本支出 | $7.0M | $33.5M |
| 自由现金流率自由现金流/营收 | 19.3% | 47.1% |
| 资本支出强度资本支出/营收 | 0.4% | 10.4% |
| 现金转化率经营现金流/净利润 | — | 28.39× |
| 过去12个月自由现金流最近4个季度 | $23.8M | $56.8M |
8季度趋势，按日历期对齐
经营现金流INFURMAX
| Q4 25 | $7.1M | $40.9M | ||
| Q3 25 | $8.5M | $17.7M | ||
| Q2 25 | $7.0M | $4.6M | ||
| Q1 25 | $1.8M | $5.7M | ||
| Q4 24 | $7.9M | $59.7M | ||
| Q3 24 | $9.8M | $17.6M | ||
| Q2 24 | $2.3M | $15.9M | ||
| Q1 24 | $377.0K | $9.4M |
自由现金流INFURMAX
| Q4 25 | $7.0M | $33.5M | ||
| Q3 25 | $8.4M | $16.4M | ||
| Q2 25 | $6.8M | $2.9M | ||
| Q1 25 | $1.6M | $4.0M | ||
| Q4 24 | $7.4M | $53.0M | ||
| Q3 24 | $9.8M | $16.3M | ||
| Q2 24 | $2.0M | $14.0M | ||
| Q1 24 | $195.0K | $6.8M |
自由现金流率INFURMAX
| Q4 25 | 19.3% | 47.1% | ||
| Q3 25 | 23.1% | 22.4% | ||
| Q2 25 | 18.9% | 4.0% | ||
| Q1 25 | 4.7% | 5.3% | ||
| Q4 24 | 21.9% | 73.2% | ||
| Q3 24 | 27.7% | 20.8% | ||
| Q2 24 | 5.9% | 17.8% | ||
| Q1 24 | 0.6% | 8.6% |
资本支出强度INFURMAX
| Q4 25 | 0.4% | 10.4% | ||
| Q3 25 | 0.2% | 1.8% | ||
| Q2 25 | 0.6% | 2.2% | ||
| Q1 25 | 0.4% | 2.3% | ||
| Q4 24 | 1.6% | 9.1% | ||
| Q3 24 | 0.1% | 1.7% | ||
| Q2 24 | 1.0% | 2.4% | ||
| Q1 24 | 0.6% | 3.3% |
现金转化率INFURMAX
| Q4 25 | — | 28.39× | ||
| Q3 25 | 3.76× | 4.45× | ||
| Q2 25 | 2.70× | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 10.28× | ||
| Q3 24 | 5.45× | 18.22× | ||
| Q2 24 | 3.22× | 4.29× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INFU
| Patient Services | $20.0M | 55% |
| Device Solutions | $14.4M | 40% |
| Other | $1.9M | 5% |
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
